The Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment

• Status: Recruiting
• Trial end date: 2030-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Efficacy of Ivermectin in larger doses in COVID-19 treatment

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Tanta University
• Treatments: Chloroquine; Chloroquine diphosphate; Ivermectin; Nitazoxanide

Criteria

Inclusion Criteria:

• Patients with covid 19

Exclusion Criteria:

• Allergy or side effects to treatment